Evidence map›Paper›PMID 33940162›Full record

ArticleAnnals of vascular surgery2021

Arterial Thrombotic Sequalae After Covid-19: Mind the Gap.

Maria Pia Borrelli, Adelaide Buora, Paola Scrivere, Massimo Sponza, Paolo Frigatti

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Annals of vascular surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Acute Limb Ischemia in COVID-19: A Systematic Review.The International journal of angiology : official publication of the International College of Angiology, Inc · 2023
    Review
  5. Multiple Arterial Thrombosis after COVID-19: A Case Report.Vascular specialist international · 2023
    Article
  6. Article
  7. Article
  8. Covid-19 Delta variant resulting in multi system thromboembolic disease.Annals of vascular surgery. Brief reports and innovations · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maria Pia BorrelliUnit of Vascular and Endovascular Surgery, General Surgery Department, University Hospital of Udine, Udine, Italy. Electronic address: borrelli.mp@gmail.com.
Adelaide BuoraUnit of Vascular and Endovascular Surgery, General Surgery Department, University Hospital of Udine, Udine, Italy.
Paola ScrivereUnit of Vascular and Endovascular Surgery, General Surgery Department, University Hospital of Udine, Udine, Italy.
Massimo SponzaUnit of Interventional Radiology, Diagnostic Imaging Department, University Hospital of Udine, Udine, Italy.
Paolo FrigattiUnit of Vascular and Endovascular Surgery, General Surgery Department, University Hospital of Udine, Udine, Italy.
University of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Investigations have shown that infection from the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is responsible also for initiating severe inflammatory responses that can lead macrovascular and microvascular thrombosis. Several studies have already described acute limb ischemia and peripheral arterial disease in critically ill patients with Coronavirus disease 2019 (Covid-19), as well as coronary artery disease and ischemic stroke as a manifestation usually associated with respiratory distress. However, what still remains unclear is how long inflammation and thrombotic derangements can last after recovery from the symptoms of Covid-19. Hence, in this article we report 3 cases of arterial thrombotic sequalae after this viral infection. To the best of our knowledge, this is the first cases' series that had described different delayed vascular arterial complications, which occurred after the index infection, with a negative nasopharyngeal swab and Covid-19 systemic symptoms resumption. A better understanding of the coagulopathy in Covid-19 could have an essential role to guide prevention and treatment of arterial thromboembolic events, both during and after the viral infection. Further investigations are required to confirm these data and to estabilish the type, dose and duration of anticoagulant/antiplatelet therapy not just during but also after Covid-19 infection.

Indexed as

AgedAnticoagulantsArterial Occlusive DiseasesCOVID-19FemaleFibrinolytic AgentsHumansMaleMiddle AgedPlatelet Aggregation InhibitorsRisk FactorsThrombolytic TherapyThrombosisTime FactorsTreatment OutcomeAnticoagulantsFibrinolytic AgentsPlatelet Aggregation InhibitorsArterial thrombotic sequalaedelayed vascular complicationSARS-CoV-2

Identifiers

PMID33940162
PMCPMC8087612
OpenAlexW3157109093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.